Moreover, immune evasion mediated by B2M loss was frequently observed in microsatellite instability (MSI) high tumors, and tumor with B2M loss was more resistant to immune checkpoint blockage (ICB) therapy11. The gene discussed is B2M; the disease is neoplasm.